Accuray Incorporated - Common Stock (ARAY)

Accuray (ARAY) Q2 2026 Earnings Call Transcript

San Francisco, CA – October 3, 2025 – In a move set to redefine the landscape of radiation oncology, Leo Cancer Care officially introduced its groundbreaking Upright Photon Therapy System, "Grace," at the ASTRO 2025 meeting in San Francisco on September 28, 2025. This innovative system challenges decades of conventional practice by

Paris, France – October 2, 2025 – Nanobiotix (NASDAQ: NBTX) witnessed a significant surge in its stock price today, jumping 11.6%, following the announcement of highly encouraging initial data from a Phase 1 study of its lead product, JNJ-1900 (NBTXR3), in patients with locally advanced esophageal adenocarcinoma. This pivotal development, revealed

Accuray Inc (ARAY) reported mixed Q4 2025 results, beating revenue estimates but missing EPS forecasts. Shares fell 6% post-earnings amid investor concerns over profitability. The company highlighted service growth and completed debt refinancing.

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Russell 2000 ETF (ARCA: IWM) up 2.7%, its strongest session in a month, driven by positive economic data & increased consumer spending, boosting confidence in US economy.